In the years to come, we are going to see a crop of biotechnology and other projects with global potential. Breakthrough innovations will not happen by accident but will rather result from a pre-programmed process, supported, among others, by the National Centre for Research and Development under the “Fast Track” scheme. Indeed, Bioceltix, a start-up from Wrocław is one of the companies that develop its projects under the latter programme. The company’ aim is to market veterinary biological drugs based on mesenchymal stem cells (MSC). More here.
